Skip to content

morphine plus Naloxone in cesarian

Comparison of pain severity and side effects of intrathecal injection of morphine and morphine plus Naloxone in cesarian patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140524017811N8
Enrollment
60
Registered
2018-12-10
Start date
2018-11-06
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean. Encounter for cesarean delivery without indication

Interventions

Intervention 1: Intervention group: Patients in both case and control group will receive 10 mg of 0.5 % bupivacaine plus 100 µg of morphine and 20 ng naloxone of Tolid daru companies intrathecaly. Int

Sponsors

Sari University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patents admit in Emam hospital For cesarian ASA classification 1or 2 60 -80 Kg weight first or second pregnancy

Exclusion criteria

Exclusion criteria: Patients who used opiate drugs before cesarean section consumption of any medicine to reduce itching unsuccessful spinal anesthesia prolong surgery

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: The pain level will be evaluated at 2, 4, 6 and after 24 hours after surgery. Method of measurement: Visual Analogue Scale(VAS).

Secondary

MeasureTime frame
Nausia. Timepoint: it will be evaluated at 2, 4, 6 and 24 hours after surgery. Method of measurement: asking the patient.;Itching. Timepoint: will be evaluated at 2, 4, 6 hours after surgery. Method of measurement: asking the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Habibi

Sari University of Medical Sciences

mhabibi@mazums.ac.ir+98 11 3304 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026